Guardant Health, Inc. Quarterly Depreciation in USD from Q3 2017 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Guardant Health, Inc. quarterly/annual Depreciation history and growth rate from Q3 2017 to Q3 2024.
Guardant Health, Inc. Depreciation for the quarter ending September 30, 2024 was $10.1M, a 1.94% decline year-over-year.
Guardant Health, Inc. Depreciation for the twelve months ending September 30, 2024 was $40.4M, a 2.8% increase year-over-year.
Guardant Health, Inc. annual Depreciation for 2023 was $40M, a 19.8% increase from 2022.
Guardant Health, Inc. annual Depreciation for 2022 was $33.4M, a 65.3% increase from 2021.
Guardant Health, Inc. annual Depreciation for 2021 was $20.2M, a 43.3% increase from 2020.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$40.4M	$10.1M	-$200K	-1.94%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$40.6M	$10.1M	+$200K	+2.02%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$40.4M	$10M	+$400K	+4.17%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$40M	$10.2M	+$700K	+7.37%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	$39.3M	$10.3M	+$1.2M	+13.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-06
Q2 2023	$38.1M	$9.9M	+$1.8M	+22.2%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$36.3M	$9.6M	+$2.9M	+43.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$33.4M	$9.5M	+$3.9M	+69.6%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$29.5M	$9.1M	+$4.1M	+82%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	$25.4M	$8.1M	+$3M	+58.8%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$22.4M	$6.7M	+$2.2M	+48.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$20.2M	$5.6M	+$1.5M	+36.6%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	$18.7M	$5M	+$1.2M	+31.6%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$17.5M	$5.1M	+$1.9M	+59.4%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$15.6M	$4.5M	+$1.5M	+50%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$14.1M	$4.1M	+$1.6M	+64%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-23
Q3 2020	$12.5M	$3.8M	+$1.3M	+52%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$11.2M	$3.2M	+$1M	+45.5%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$10.2M	$3M	+$900K	+42.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$9.3M	$2.5M	-$3.6M	-59%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-24
Q3 2019	$12.9M	$2.5M	+$800K	+47.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$12.1M	$2.2M	+$900K	+69.2%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$11.2M	$2.1M	+$900K	+75%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$10.3M	$6.1M			Oct 1, 2018	Dec 31, 2018	10-K	2020-03-02
Q3 2018		$1.7M	+$600K	+54.5%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		$1.3M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018		$1.2M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q3 2017		$1.1M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.